Cogent Biosciences, Inc.
COGT
$39.16
$0.180.46%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 16.50% | -34.52% | -43.62% | 8.04% | 20.24% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 5.74% | 6.00% | 17.20% | 85.64% | -13.06% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 16.31% | -33.78% | -42.77% | 9.49% | 19.44% |
|
|
|||||
| Total Current Assets | 16.31% | -33.78% | -42.77% | 9.49% | 19.44% |
| Net Property, Plant & Equipment | -13.52% | -12.20% | -11.22% | -12.45% | -10.51% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -0.78% | 0.00% | 0.00% | -0.04% | 0.00% |
| Total Assets | 10.92% | -36.08% | -40.39% | 4.61% | 8.04% |
|
|
|||||
| Total Accounts Payable | 6.43% | 85.24% | -9.07% | 12.75% | 52.62% |
| Total Accrued Expenses | 19.54% | 32.64% | 73.56% | 226.60% | 56.89% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 12.24% | 12.41% | 12.50% | 12.91% | 13.10% |
| Total Finance Division Other Current Liabilities | 319.93% | 405.16% | -23.90% | -15.42% | -33.19% |
| Total Other Current Liabilities | 319.93% | 405.16% | -23.90% | -15.42% | -33.19% |
| Total Current Liabilities | 17.34% | 46.04% | 34.43% | 45.96% | 52.79% |
|
|
|||||
| Total Current Liabilities | 17.34% | 46.04% | 34.43% | 45.96% | 52.79% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -10.46% | -9.92% | -9.43% | -8.96% | -8.53% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 78.02% | 111.21% | 20.50% | 28.72% | 31.99% |
|
|
|||||
| Common Stock & APIC | 28.71% | 7.33% | 20.87% | 25.41% | 25.55% |
| Retained Earnings | -37.19% | -39.40% | -40.71% | -42.39% | -44.11% |
| Treasury Stock & Other | -76.79% | 106.77% | 520.51% | 81.71% | 620.93% |
| Total Common Equity | -4.66% | -81.81% | -44.64% | -26.33% | -15.98% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -2.43% | -5.44% | -51.31% | 84.23% | 84.23% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -2.43% | -5.44% | -51.31% | 84.23% | 84.23% |
|
|
|||||
| Total Common Equity | -4.66% | -81.81% | -44.64% | -26.33% | -15.98% |
| Total Preferred Equity | -2.43% | -5.44% | -51.31% | 84.23% | 84.23% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -3.88% | -58.46% | -48.15% | -0.59% | 3.88% |
|
|
|||||